| Year |
Citation |
Score |
| 2023 |
Pedrosa MA, Labandeira CM, Lago-Baameiro N, Valenzuela R, Pardo M, Labandeira-Garcia JL, Rodriguez-Perez AI. Extracellular Vesicles and Their Renin-Angiotensin Cargo as a Link between Metabolic Syndrome and Parkinson's Disease. Antioxidants (Basel, Switzerland). 12. PMID 38136165 DOI: 10.3390/antiox12122045 |
0.33 |
|
| 2023 |
Rivas-Santisteban R, Rico AJ, Muñoz A, Rodríguez-Pérez AI, Reyes-Resina I, Navarro G, Labandeira-García JL, Lanciego JL, Franco R. Boolean analysis shows a high proportion of dopamine D receptors interacting with adenosine A receptors in striatal medium spiny neurons of mouse and non-human primate models of Parkinson's disease. Neurobiology of Disease. 188: 106341. PMID 37918757 DOI: 10.1016/j.nbd.2023.106341 |
0.381 |
|
| 2023 |
Lopez-Lopez A, Valenzuela R, Rodriguez-Perez AI, Guerra MJ, Labandeira-Garcia JL, Muñoz A. Interactions between Angiotensin Type-1 Antagonists, Statins, and ROCK Inhibitors in a Rat Model of L-DOPA-Induced Dyskinesia. Antioxidants (Basel, Switzerland). 12. PMID 37507992 DOI: 10.3390/antiox12071454 |
0.322 |
|
| 2022 |
Rodríguez-Pallares J, García-Garrote M, Parga JA, Labandeira-García JL. Combined cell-based therapy strategies for the treatment of Parkinson's disease: focus on mesenchymal stromal cells. Neural Regeneration Research. 18: 478-484. PMID 36018150 DOI: 10.4103/1673-5374.350193 |
0.748 |
|
| 2021 |
Rodriguez-Pallares J, Garcia-Garrote M, Parga JA, Labandeira-Garcia JL. Dose-dependent effect of mesenchymal stromal cells co-grafted with dopaminergic neurons in a Parkinson's disease rat model. Journal of Cellular and Molecular Medicine. PMID 34535974 DOI: 10.1111/jcmm.16900 |
0.732 |
|
| 2021 |
Garcia-Garrote M, Parga JA, Labandeira PJ, Labandeira-Garcia JL, Rodriguez-Pallares J. Dopamine regulates adult neurogenesis in the ventricular-subventricular zone via dopamine D3 angiotensin type 2 receptor interactions. Stem Cells (Dayton, Ohio). PMID 34521155 DOI: 10.1002/stem.3457 |
0.743 |
|
| 2021 |
Martín-Montañez E, Valverde N, Ladrón de Guevara-Miranda D, Lara E, Romero-Zerbo YS, Millon C, Boraldi F, Ávila-Gámiz F, Pérez-Cano AM, Garrido-Gil P, Labandeira-Garcia JL, Santin LJ, Pavia J, Garcia-Fernandez M. Insulin-like growth factor II prevents oxidative and neuronal damage in cellular and mice models of Parkinson's disease. Redox Biology. 46: 102095. PMID 34418603 DOI: 10.1016/j.redox.2021.102095 |
0.347 |
|
| 2021 |
Rivas-Santisteban R, Lillo J, Muñoz A, Rodríguez-Pérez AI, Labandeira-García JL, Navarro G, Franco R. Novel Interactions Involving the Mas Receptor Show Potential of the Renin-Angiotensin system in the Regulation of Microglia Activation: Altered Expression in Parkinsonism and Dyskinesia. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. PMID 33474655 DOI: 10.1007/s13311-020-00986-4 |
0.343 |
|
| 2020 |
Garrido-Gil P, Rodriguez-Perez AI, Lage L, Labandeira-Garcia JL. Estrogen deficiency and colonic function: surgical menopause and sex differences in angiotensin and dopamine receptor interaction. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. PMID 32991714 DOI: 10.1093/gerona/glaa244 |
0.304 |
|
| 2020 |
Rivas-Santisteban R, Rodriguez-Perez AI, Muñoz A, Reyes-Resina I, Labandeira-García JL, Navarro G, Franco R. Angiotensin AT and AT receptor heteromer expression in the hemilesioned rat model of Parkinson's disease that increases with levodopa-induced dyskinesia. Journal of Neuroinflammation. 17: 243. PMID 32807174 DOI: 10.1186/s12974-020-01908-z |
0.354 |
|
| 2020 |
Muñoz A, Lopez-Lopez A, Labandeira CM, Labandeira-Garcia JL. Interactions Between the Serotonergic and Other Neurotransmitter Systems in the Basal Ganglia: Role in Parkinson's Disease and Adverse Effects of L-DOPA. Frontiers in Neuroanatomy. 14: 26. PMID 32581728 DOI: 10.3389/fnana.2020.00026 |
0.366 |
|
| 2020 |
Diaz-Ruiz C, Villar-Cheda B, Dominguez-Meijide A, Garrido-Gil P, Guerra MJ, Labandeira-Garcia JL. Aging-Related Overactivity of the Angiotensin/AT1 Axis Decreases Sirtuin 3 Levels in the Substantia Nigra, Which Induces Vulnerability to Oxidative Stress and Neurodegeneration. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. 75: 416-424. PMID 30412227 DOI: 10.1093/gerona/gly259 |
0.363 |
|
| 2019 |
Rodriguez-Perez AI, Garrido-Gil P, Pedrosa MA, Garcia-Garrote M, Valenzuela R, Navarro G, Franco R, Labandeira-Garcia JL. Angiotensin type 2 receptors: role in aging and neuroinflammation in the substantia nigra. Brain, Behavior, and Immunity. PMID 31863823 DOI: 10.1016/j.bbi.2019.12.011 |
0.336 |
|
| 2019 |
Garcia-Garrote M, Perez-Villalba A, Garrido-Gil P, Belenguer G, Parga JA, Perez-Sanchez F, Labandeira-Garcia JL, Fariñas I, Rodriguez-Pallares J. Interaction between Angiotensin Type 1, Type 2, and Mas Receptors to Regulate Adult Neurogenesis in the Brain Ventricular-Subventricular Zone. Cells. 8. PMID 31801296 DOI: 10.3390/Cells8121551 |
0.714 |
|
| 2019 |
Rodriguez-Perez AI, Sucunza D, Pedrosa MA, Garrido-Gil P, Kulisevsky J, Lanciego JL, Labandeira-Garcia JL. Angiotensin Type 1 Receptor Antagonists Protect Against Alpha-Synuclein-Induced Neuroinflammation and Dopaminergic Neuron Death. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 15: 1063-1081. PMID 29987762 DOI: 10.1007/s13311-018-0646-z |
0.356 |
|
| 2019 |
Muñoz A, Corrêa CL, Lopez-Lopez A, Costa-Besada MA, Diaz-Ruiz C, Labandeira-Garcia JL. Physical Exercise Improves Aging-Related Changes in Angiotensin, IGF-1, SIRT1, SIRT3, and VEGF in the Substantia Nigra. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. 73: 1594-1601. PMID 29659739 DOI: 10.1093/gerona/gly072 |
0.347 |
|
| 2018 |
Parga JA, Rodriguez-Perez AI, Garcia-Garrote M, Rodriguez-Pallares J, Labandeira-Garcia JL. Data on the effect of Angiotensin II and 6-hydroxydopamine on reactive oxygen species production, antioxidant gene expression and viability of different neuronal cell lines. Data in Brief. 21: 934-942. PMID 30426047 DOI: 10.1016/J.Dib.2018.10.069 |
0.722 |
|
| 2018 |
Parga JA, Rodriguez-Perez AI, Garcia-Garrote M, Rodriguez-Pallares J, Labandeira-Garcia JL. Angiotensin II induces oxidative stress and upregulates neuroprotective signaling from the NRF2 and KLF9 pathway in dopaminergic cells. Free Radical Biology & Medicine. 129: 394-406. PMID 30315936 DOI: 10.1016/J.Freeradbiomed.2018.10.409 |
0.752 |
|
| 2018 |
Garrido-Gil P, Dominguez-Meijide A, Moratalla R, Guerra MJ, Labandeira-Garcia JL. Aging-related dysregulation in enteric dopamine and angiotensin system interactions: implications for gastrointestinal dysfunction in the elderly. Oncotarget. 9: 10834-10846. PMID 29541380 DOI: 10.18632/Oncotarget.24330 |
0.352 |
|
| 2018 |
Garrido-Gil P, Rodriguez-Perez AI, Dominguez-Meijide A, Guerra MJ, Labandeira-Garcia JL. Bidirectional Neural Interaction Between Central Dopaminergic and Gut Lesions in Parkinson's Disease Models. Molecular Neurobiology. 55: 7297-7316. PMID 29404956 DOI: 10.1007/s12035-018-0937-8 |
0.401 |
|
| 2017 |
Costa-Besada MA, Valenzuela R, Garrido-Gil P, Villar-Cheda B, Parga JA, Lanciego JL, Labandeira-Garcia JL. Paracrine and Intracrine Angiotensin 1-7/Mas Receptor Axis in the Substantia Nigra of Rodents, Monkeys, and Humans. Molecular Neurobiology. 55: 5847-5867. PMID 29086247 DOI: 10.1007/s12035-017-0805-y |
0.375 |
|
| 2017 |
Villar-Cheda B, Costa-Besada MA, Valenzuela R, Perez-Costas E, Melendez-Ferro M, Labandeira-Garcia JL. The intracellular angiotensin system buffers deleterious effects of the extracellular paracrine system. Cell Death & Disease. 8: e3044. PMID 28880266 DOI: 10.1038/Cddis.2017.439 |
0.326 |
|
| 2017 |
Navarro G, Borroto-Escuela D, Angelats E, Etayo Í, Reyes-Resina I, Pulido-Salgado M, Rodriguez-Perez AI, Canela EI, Saura J, Lanciego JL, Labandeira-García JL, Saura CA, Fuxe K, Franco R. Receptor-heteromer mediated regulation of endocannabinoid signaling in activated microglia. Role of CB1 and CB2 receptors and relevance for Alzheimer's disease and levodopa-induced dyskinesia. Brain, Behavior, and Immunity. PMID 28843453 DOI: 10.1016/J.Bbi.2017.08.015 |
0.337 |
|
| 2017 |
Dopeso-Reyes IG, Sucunza D, Rico AJ, Pignataro D, Marín-Ramos D, Roda E, Rodríguez-Pérez AI, Labandeira-García JL, Lanciego JL. Glucocerebrosidase expression patterns in the non-human primate brain. Brain Structure & Function. 223: 343-355. PMID 28835999 DOI: 10.1007/s00429-017-1504-1 |
0.305 |
|
| 2017 |
Parga JA, García-Garrote M, Martínez S, Raya Á, Labandeira-García JL, Rodríguez-Pallares J. Prostaglandin EP2 Receptors Mediate Mesenchymal Stromal Cell-Neuroprotective Effects on Dopaminergic Neurons. Molecular Neurobiology. PMID 28717970 DOI: 10.1007/S12035-017-0681-5 |
0.761 |
|
| 2017 |
Garrido-Gil P, Fernandez-Rodríguez P, Rodríguez-Pallares J, Labandeira-Garcia JL. Laser capture microdissection protocol for gene expression analysis in the brain. Histochemistry and Cell Biology. 148: 299-311. PMID 28560490 DOI: 10.1007/S00418-017-1585-1 |
0.647 |
|
| 2017 |
Labandeira-Garcia JL, Rodríguez-Perez AI, Garrido-Gil P, Rodriguez-Pallares J, Lanciego JL, Guerra MJ. Brain Renin-Angiotensin System and Microglial Polarization: Implications for Aging and Neurodegeneration. Frontiers in Aging Neuroscience. 9: 129. PMID 28515690 DOI: 10.3389/Fnagi.2017.00129 |
0.713 |
|
| 2017 |
Dominguez-Meijide A, Rodriguez-Perez AI, Diaz-Ruiz C, Guerra MJ, Labandeira-Garcia JL. Dopamine modulates astroglial and microglial activity via glial renin-angiotensin system in cultures. Brain, Behavior, and Immunity. 62: 277-290. PMID 28232171 DOI: 10.1016/j.bbi.2017.02.013 |
0.408 |
|
| 2017 |
Garrido-Gil P, Rodriguez-Perez AI, Fernandez-Rodriguez P, Lanciego JL, Labandeira-Garcia JL. Expression of angiotensinogen and receptors for angiotensin and prorenin in the rat and monkey striatal neurons and glial cells. Brain Structure & Function. 222: 2559-2571. PMID 28161727 DOI: 10.1007/s00429-016-1357-z |
0.455 |
|
| 2017 |
Rodriguez-Perez AI, Borrajo A, Diaz-Ruiz C, Garrido-Gil P, Labandeira-Garcia JL. Crosstalk between insulin-like growth factor-1 and angiotensin-II in dopaminergic neurons and glial cells: role in neuroinflammation and aging. Oncotarget. 7: 30049-67. PMID 27167199 DOI: 10.18632/oncotarget.9174 |
0.386 |
|
| 2016 |
Valenzuela R, Costa-Besada MA, Iglesias-Gonzalez J, Perez-Costas E, Villar-Cheda B, Garrido-Gil P, Melendez-Ferro M, Soto-Otero R, Lanciego JL, Henrion D, Franco R, Labandeira-Garcia JL. Mitochondrial angiotensin receptors in dopaminergic neurons. Role in cell protection and aging-related vulnerability to neurodegeneration. Cell Death & Disease. 7: e2427. PMID 27763643 DOI: 10.1038/Cddis.2016.327 |
0.406 |
|
| 2016 |
Labandeira-Garcia JL, Rodriguez-Perez AI, Valenzuela R, Costa-Besada MA, Guerra MJ. Menopause and Parkinson's disease. Interaction between estrogens and brain renin-angiotensin system in dopaminergic degeneration. Frontiers in Neuroendocrinology. 43: 44-59. PMID 27693730 DOI: 10.1016/j.yfrne.2016.09.003 |
0.344 |
|
| 2016 |
Rodriguez-Pallares J, Rodriguez-Perez AI, Muñoz A, Parga JA, Toledo-Aral JJ, Labandeira-Garcia JL. Effects of Rho Kinase Inhibitors on Grafts of Dopaminergic Cell Precursors in a Rat Model of Parkinson's Disease. Stem Cells Translational Medicine. PMID 27075764 DOI: 10.5966/Sctm.2015-0182 |
0.746 |
|
| 2015 |
Franco R, Casadó-Anguera V, Muñoz A, Petrovic M, Navarro G, Moreno E, Lanciego JL, Labandeira-García JL, Cortés A, Casadó V. Hints on the Lateralization of Dopamine Binding to D1 Receptors in Rat Striatum. Molecular Neurobiology. PMID 26452359 DOI: 10.1007/s12035-015-9468-8 |
0.313 |
|
| 2015 |
Diaz-Ruiz C, Rodriguez-Perez AI, Beiroa D, Rodriguez-Pallares J, Labandeira-Garcia JL. Reciprocal regulation between sirtuin-1 and angiotensin-II in the substantia nigra: implications for aging and neurodegeneration. Oncotarget. 6: 26675-89. PMID 26384348 DOI: 10.18632/Oncotarget.5596 |
0.733 |
|
| 2015 |
Martínez-Pinilla E, Rodríguez-Pérez AI, Navarro G, Aguinaga D, Moreno E, Lanciego JL, Labandeira-García JL, Franco R. Dopamine D2 and angiotensin II type 1 receptors form functional heteromers in rat striatum. Biochemical Pharmacology. 96: 131-42. PMID 25986885 DOI: 10.1016/j.bcp.2015.05.006 |
0.336 |
|
| 2015 |
Rodriguez-Perez AI, Borrajo A, Valenzuela R, Lanciego JL, Labandeira-Garcia JL. Critical period for dopaminergic neuroprotection by hormonal replacement in menopausal rats. Neurobiology of Aging. 36: 1194-208. PMID 25432430 DOI: 10.1016/j.neurobiolaging.2014.10.028 |
0.369 |
|
| 2015 |
Rodriguez-Perez AI, Borrajo A, Rodriguez-Pallares J, Guerra MJ, Labandeira-Garcia JL. Interaction between NADPH-oxidase and Rho-kinase in angiotensin II-induced microglial activation. Glia. 63: 466-82. PMID 25377425 DOI: 10.1002/Glia.22765 |
0.696 |
|
| 2014 |
Labandeira-Garcia JL, Rodríguez-Perez AI, Villar-Cheda B, Borrajo A, Dominguez-Meijide A, Guerra MJ. Rho Kinase and Dopaminergic Degeneration: A Promising Therapeutic Target for Parkinson's Disease. The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry. PMID 25323761 DOI: 10.1177/1073858414554954 |
0.356 |
|
| 2014 |
Labandeira-García JL, Garrido-Gil P, Rodriguez-Pallares J, Valenzuela R, Borrajo A, Rodríguez-Perez AI. Brain renin-angiotensin system and dopaminergic cell vulnerability. Frontiers in Neuroanatomy. 8: 67. PMID 25071471 DOI: 10.3389/Fnana.2014.00067 |
0.74 |
|
| 2014 |
Sierra S, Luquin N, Rico AJ, Gómez-Bautista V, Roda E, Dopeso-Reyes IG, Vázquez A, Martínez-Pinilla E, Labandeira-García JL, Franco R, Lanciego JL. Detection of cannabinoid receptors CB1 and CB2 within basal ganglia output neurons in macaques: changes following experimental parkinsonism. Brain Structure & Function. PMID 24972960 DOI: 10.1007/s00429-014-0823-8 |
0.351 |
|
| 2014 |
Borrajo A, Rodriguez-Perez AI, Villar-Cheda B, Guerra MJ, Labandeira-Garcia JL. Inhibition of the microglial response is essential for the neuroprotective effects of Rho-kinase inhibitors on MPTP-induced dopaminergic cell death. Neuropharmacology. 85: 1-8. PMID 24878243 DOI: 10.1016/j.neuropharm.2014.05.021 |
0.379 |
|
| 2014 |
Villar-Cheda B, Dominguez-Meijide A, Valenzuela R, Granado N, Moratalla R, Labandeira-Garcia JL. Aging-related dysregulation of dopamine and angiotensin receptor interaction. Neurobiology of Aging. 35: 1726-38. PMID 24529758 DOI: 10.1016/J.Neurobiolaging.2014.01.017 |
0.411 |
|
| 2014 |
Borrajo A, Rodriguez-Perez AI, Diaz-Ruiz C, Guerra MJ, Labandeira-Garcia JL. Microglial TNF-α mediates enhancement of dopaminergic degeneration by brain angiotensin. Glia. 62: 145-57. PMID 24272709 DOI: 10.1002/glia.22595 |
0.392 |
|
| 2014 |
Dominguez-Meijide A, Villar-Cheda B, Garrido-Gil P, Sierrra-Paredes G, Guerra MJ, Labandeira-Garcia JL. Effect of chronic treatment with angiotensin type 1 receptor antagonists on striatal dopamine levels in normal rats and in a rat model of Parkinson's disease treated with L-DOPA. Neuropharmacology. 76: 156-68. PMID 23973568 DOI: 10.1016/j.neuropharm.2013.07.016 |
0.379 |
|
| 2013 |
Garrido-Gil P, Rodriguez-Pallares J, Dominguez-Meijide A, Guerra MJ, Labandeira-Garcia JL. Brain angiotensin regulates iron homeostasis in dopaminergic neurons and microglial cells. Experimental Neurology. 250: 384-96. PMID 24184051 DOI: 10.1016/J.Expneurol.2013.10.013 |
0.747 |
|
| 2013 |
Labandeira-Garcia JL, Rodriguez-Pallares J, Dominguez-Meijide A, Valenzuela R, Villar-Cheda B, Rodríguez-Perez AI. Dopamine-angiotensin interactions in the basal ganglia and their relevance for Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 28: 1337-42. PMID 23925977 DOI: 10.1002/Mds.25614 |
0.749 |
|
| 2013 |
Rodriguez-Perez AI, Dominguez-Meijide A, Lanciego JL, Guerra MJ, Labandeira-Garcia JL. Inhibition of Rho kinase mediates the neuroprotective effects of estrogen in the MPTP model of Parkinson's disease. Neurobiology of Disease. 58: 209-19. PMID 23774254 DOI: 10.1016/j.nbd.2013.06.004 |
0.314 |
|
| 2013 |
Rodriguez-Perez AI, Dominguez-Meijide A, Lanciego JL, Guerra MJ, Labandeira-Garcia JL. Dopaminergic degeneration is enhanced by chronic brain hypoperfusion and inhibited by angiotensin receptor blockage. Age (Dordrecht, Netherlands). 35: 1675-90. PMID 22986582 DOI: 10.1007/s11357-012-9470-2 |
0.433 |
|
| 2013 |
Garrido-Gil P, Valenzuela R, Villar-Cheda B, Lanciego JL, Labandeira-Garcia JL. Expression of angiotensinogen and receptors for angiotensin and prorenin in the monkey and human substantia nigra: an intracellular renin-angiotensin system in the nigra. Brain Structure & Function. 218: 373-88. PMID 22407459 DOI: 10.1007/s00429-012-0402-9 |
0.416 |
|
| 2012 |
Labandeira-Garcia JL, Rodriguez-Pallares J, Rodríguez-Perez AI, Garrido-Gil P, Villar-Cheda B, Valenzuela R, Guerra MJ. Brain angiotensin and dopaminergic degeneration: relevance to Parkinson's disease. American Journal of Neurodegenerative Disease. 1: 226-44. PMID 23383395 |
0.743 |
|
| 2012 |
Rodriguez-Pallares J, Joglar B, Muñoz-Manchado AB, Villadiego J, Toledo-Aral JJ, Labandeira-Garcia JL. Cografting of carotid body cells improves the long-term survival, fiber outgrowth and functional effects of grafted dopaminergic neurons. Regenerative Medicine. 7: 309-22. PMID 22594325 DOI: 10.2217/Rme.12.22 |
0.727 |
|
| 2012 |
Villar-Cheda B, Dominguez-Meijide A, Joglar B, Rodriguez-Perez AI, Guerra MJ, Labandeira-Garcia JL. Involvement of microglial RhoA/Rho-kinase pathway activation in the dopaminergic neuron death. Role of angiotensin via angiotensin type 1 receptors. Neurobiology of Disease. 47: 268-79. PMID 22542954 DOI: 10.1016/j.nbd.2012.04.010 |
0.443 |
|
| 2012 |
Garrido-Gil P, Joglar B, Rodriguez-Perez AI, Guerra MJ, Labandeira-Garcia JL. Involvement of PPAR-γ in the neuroprotective and anti-inflammatory effects of angiotensin type 1 receptor inhibition: effects of the receptor antagonist telmisartan and receptor deletion in a mouse MPTP model of Parkinson's disease. Journal of Neuroinflammation. 9: 38. PMID 22356806 DOI: 10.1186/1742-2094-9-38 |
0.372 |
|
| 2012 |
Rodriguez-Perez AI, Valenzuela R, Villar-Cheda B, Guerra MJ, Labandeira-Garcia JL. Dopaminergic neuroprotection of hormonal replacement therapy in young and aged menopausal rats: role of the brain angiotensin system. Brain : a Journal of Neurology. 135: 124-38. PMID 22189567 DOI: 10.1093/brain/awr320 |
0.333 |
|
| 2012 |
Rodriguez-Pallares J, Parga JA, Joglar B, Guerra MJ, Labandeira-Garcia JL. Mitochondrial ATP-sensitive potassium channels enhance angiotensin-induced oxidative damage and dopaminergic neuron degeneration. Relevance for aging-associated susceptibility to Parkinson's disease. Age (Dordrecht, Netherlands). 34: 863-80. PMID 21713375 DOI: 10.1007/S11357-011-9284-7 |
0.727 |
|
| 2012 |
Villar-Cheda B, Valenzuela R, Rodriguez-Perez AI, Guerra MJ, Labandeira-Garcia JL. Aging-related changes in the nigral angiotensin system enhances proinflammatory and pro-oxidative markers and 6-OHDA-induced dopaminergic degeneration. Neurobiology of Aging. 33: 204.e1-11. PMID 20888078 DOI: 10.1016/j.neurobiolaging.2010.08.006 |
0.364 |
|
| 2011 |
Labandeira-Garcia JL, Rodriguez-Pallares J, Villar-Cheda B, Rodríguez-Perez AI, Garrido-Gil P, Guerra MJ. Aging, Angiotensin system and dopaminergic degeneration in the substantia nigra. Aging and Disease. 2: 257-74. PMID 22396877 |
0.738 |
|
| 2011 |
Rodriguez-Perez AI, Valenzuela R, Joglar B, Garrido-Gil P, Guerra MJ, Labandeira-Garcia JL. Renin angiotensin system and gender differences in dopaminergic degeneration. Molecular Neurodegeneration. 6: 58. PMID 21846363 DOI: 10.1186/1750-1326-6-58 |
0.378 |
|
| 2010 |
Parga JA, RodrÃguez-Pallares J, Joglar B, Diaz-Ruiz C, Guerra MJ, Labandeira-Garcia JL. Effect of inhibitors of NADPH oxidase complex and mitochondrial ATP-sensitive potassium channels on generation of dopaminergic neurons from neurospheres of mesencephalic precursors. Developmental Dynamics : An Official Publication of the American Association of Anatomists. 239: 3247-59. PMID 21046630 DOI: 10.1002/dvdy.22474 |
0.34 |
|
| 2010 |
Villar-Cheda B, Rodríguez-Pallares J, Valenzuela R, Muñoz A, Guerra MJ, Baltatu OC, Labandeira-Garcia JL. Nigral and striatal regulation of angiotensin receptor expression by dopamine and angiotensin in rodents: implications for progression of Parkinson's disease. The European Journal of Neuroscience. 32: 1695-706. PMID 20964730 DOI: 10.1111/J.1460-9568.2010.07448.X |
0.764 |
|
| 2010 |
Valenzuela R, Barroso-Chinea P, Villar-Cheda B, Joglar B, Muñoz A, Lanciego JL, Labandeira-Garcia JL. Location of prorenin receptors in primate substantia nigra: effects on dopaminergic cell death. Journal of Neuropathology and Experimental Neurology. 69: 1130-42. PMID 20940627 DOI: 10.1097/NEN.0b013e3181fa0308 |
0.475 |
|
| 2010 |
Rodriguez-Perez AI, Valenzuela R, Villar-Cheda B, Guerra MJ, Lanciego JL, Labandeira-Garcia JL. Estrogen and angiotensin interaction in the substantia nigra. Relevance to postmenopausal Parkinson's disease. Experimental Neurology. 224: 517-26. PMID 20580712 DOI: 10.1016/j.expneurol.2010.05.015 |
0.41 |
|
| 2009 |
Rodriguez-Pallares J, Parga JA, Joglar B, Guerra MJ, Labandeira-Garcia JL. The mitochondrial ATP-sensitive potassium channel blocker 5-hydroxydecanoate inhibits toxicity of 6-hydroxydopamine on dopaminergic neurons. Neurotoxicity Research. 15: 82-95. PMID 19384591 DOI: 10.1007/S12640-009-9010-8 |
0.71 |
|
| 2009 |
Joglar B, Rodriguez-Pallares J, Rodriguez-Perez AI, Rey P, Guerra MJ, Labandeira-Garcia JL. The inflammatory response in the MPTP model of Parkinson's disease is mediated by brain angiotensin: relevance to progression of the disease. Journal of Neurochemistry. 109: 656-69. PMID 19245663 DOI: 10.1111/J.1471-4159.2009.05999.X |
0.75 |
|
| 2009 |
Villar-Cheda B, Sousa-Ribeiro D, Rodriguez-Pallares J, Rodriguez-Perez AI, Guerra MJ, Labandeira-Garcia JL. Aging and sedentarism decrease vascularization and VEGF levels in the rat substantia nigra. Implications for Parkinson's disease. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 29: 230-4. PMID 18957989 DOI: 10.1038/Jcbfm.2008.127 |
0.699 |
|
| 2008 |
Rodriguez-Pallares J, Rey P, Parga JA, Muñoz A, Guerra MJ, Labandeira-Garcia JL. Brain angiotensin enhances dopaminergic cell death via microglial activation and NADPH-derived ROS. Neurobiology of Disease. 31: 58-73. PMID 18499466 DOI: 10.1016/J.Nbd.2008.03.003 |
0.778 |
|
| 2008 |
Parga JA, Rodriguez-Pallares J, Blanco V, Guerra MJ, Labandeira-Garcia JL. Different effects of anti-sonic hedgehog antibodies and the hedgehog pathway inhibitor cyclopamine on generation of dopaminergic neurons from neurospheres of mesencephalic precursors. Developmental Dynamics : An Official Publication of the American Association of Anatomists. 237: 909-17. PMID 18330924 DOI: 10.1002/Dvdy.21481 |
0.738 |
|
| 2007 |
Rodriguez-Pallares J, Parga JA, Muñoz A, Rey P, Guerra MJ, Labandeira-Garcia JL. Mechanism of 6-hydroxydopamine neurotoxicity: the role of NADPH oxidase and microglial activation in 6-hydroxydopamine-induced degeneration of dopaminergic neurons. Journal of Neurochemistry. 103: 145-56. PMID 17573824 DOI: 10.1111/J.1471-4159.2007.04699.X |
0.749 |
|
| 2007 |
Parga JA, Rodriguez-Pallares J, Guerra MJ, Labandeira-Garcia JL. Effects of GABA and GABA receptor inhibition on differentiation of mesencephalic precursors into dopaminergic neurons in vitro. Developmental Neurobiology. 67: 1549-59. PMID 17525990 DOI: 10.1002/dneu.20531 |
0.721 |
|
| 2007 |
Parga J, Rodriguez-Pallares J, Muñoz A, Guerra MJ, Labandeira-Garcia JL. Serotonin decreases generation of dopaminergic neurons from mesencephalic precursors via serotonin type 7 and type 4 receptors. Developmental Neurobiology. 67: 10-22. PMID 17443768 DOI: 10.1002/dneu.20306 |
0.684 |
|
| 2007 |
Rey P, Lopez-Real A, Sanchez-Iglesias S, Muñoz A, Soto-Otero R, Labandeira-Garcia JL. Angiotensin type-1-receptor antagonists reduce 6-hydroxydopamine toxicity for dopaminergic neurons. Neurobiology of Aging. 28: 555-67. PMID 16621167 DOI: 10.1016/j.neurobiolaging.2006.02.018 |
0.435 |
|
| 2006 |
Muñoz A, Rey P, Guerra MJ, Mendez-Alvarez E, Soto-Otero R, Labandeira-Garcia JL. Reduction of dopaminergic degeneration and oxidative stress by inhibition of angiotensin converting enzyme in a MPTP model of parkinsonism. Neuropharmacology. 51: 112-20. PMID 16678218 DOI: 10.1016/j.neuropharm.2006.03.004 |
0.375 |
|
| 2005 |
Rodriguez-Pallares J, Parga JA, Rey P, Guerra MJ, Labandeira-Garcia JL. Expanded mesencephalic precursors develop into grafts of densely packed dopaminergic neurons that reinnervate the surrounding striatum and induce functional responses in the striatal neurons. Synapse (New York, N.Y.). 58: 13-22. PMID 16037947 DOI: 10.1002/syn.20179 |
0.737 |
|
| 2005 |
Rodriguez-Pallares J, Guerra MJ, Labandeira-Garcia JL. Angiotensin II and interleukin-1 interact to increase generation of dopaminergic neurons from neurospheres of mesencephalic precursors. Brain Research. Developmental Brain Research. 158: 120-2. PMID 16026856 DOI: 10.1016/J.Devbrainres.2005.06.009 |
0.743 |
|
| 2005 |
Lopez-Real A, Rey P, Soto-Otero R, Mendez-Alvarez E, Labandeira-Garcia JL. Angiotensin-converting enzyme inhibition reduces oxidative stress and protects dopaminergic neurons in a 6-hydroxydopamine rat model of Parkinsonism. Journal of Neuroscience Research. 81: 865-73. PMID 16015598 DOI: 10.1002/jnr.20598 |
0.38 |
|
| 2005 |
Muñoz AM, Rey P, Parga J, Guerra MJ, Labandeira-Garcia JL. Glial overexpression of heme oxygenase-1: a histochemical marker for early stages of striatal damage. Journal of Chemical Neuroanatomy. 29: 113-26. PMID 15652698 DOI: 10.1016/j.jchemneu.2004.10.001 |
0.301 |
|
| 2004 |
Rodriguez-Pallares J, Quiroz CR, Parga JA, Guerra MJ, Labandeira-Garcia JL. Angiotensin II increases differentiation of dopaminergic neurons from mesencephalic precursors via angiotensin type 2 receptors. The European Journal of Neuroscience. 20: 1489-98. PMID 15355316 DOI: 10.1111/j.1460-9568.2004.03621.x |
0.774 |
|
| 2004 |
Muñoz AM, Rey P, Soto-Otero R, Guerra MJ, Labandeira-Garcia JL. Systemic administration of N-acetylcysteine protects dopaminergic neurons against 6-hydroxydopamine-induced degeneration. Journal of Neuroscience Research. 76: 551-62. PMID 15114627 DOI: 10.1002/jnr.20107 |
0.373 |
|
| 2003 |
Rodriguez-Pallares J, Guerra MJ, Labandeira-Garcia JL. Elimination of serotonergic cells induces a marked increase in generation of dopaminergic neurons from mesencephalic precursors. The European Journal of Neuroscience. 18: 2166-74. PMID 14622177 DOI: 10.1046/J.1460-9568.2003.02949.X |
0.732 |
|
| 2003 |
Muñoz A, Lopez-Real A, Labandeira-Garcia JL, Guerra MJ. Interaction between the noradrenergic and serotonergic systems in locomotor hyperactivity and striatal expression of Fos induced by amphetamine in rats. Experimental Brain Research. 153: 92-9. PMID 12955385 DOI: 10.1007/s00221-003-1582-6 |
0.382 |
|
| 2003 |
Lopez-Real A, Rodriguez-Pallares J, Guerra MJ, Labandeira-Garcia JL. Localization and functional significance of striatal neurons immunoreactive to aromatic L-amino acid decarboxylase or tyrosine hydroxylase in rat Parkinsonian models. Brain Research. 969: 135-46. PMID 12676374 DOI: 10.1016/S0006-8993(03)02291-1 |
0.732 |
|
| 2003 |
Muñoz A, Rodriguez-Pallares J, Guerra MJ, Labandeira-Garcia JL. Host brain regulation of dopaminergic grafts function: role of the serotonergic and noradrenergic systems in amphetamine-induced responses. Synapse (New York, N.Y.). 47: 66-76. PMID 12422375 DOI: 10.1002/Syn.10152 |
0.746 |
|
| 2001 |
RodrÃguez-Pallares J, Rey P, Soto-Otero R, Labandeira-Garcia JL. N-acetylcysteine enhances production of dopaminergic neurons from mesencephalic-derived precursor cells. Neuroreport. 12: 3935-8. PMID 11742214 DOI: 10.1097/00001756-200112210-00016 |
0.341 |
|
| 2000 |
Soto-Otero R, Méndez-Alvarez E, Hermida-Ameijeiras A, Muñoz-Patiño AM, Labandeira-Garcia JL. Autoxidation and neurotoxicity of 6-hydroxydopamine in the presence of some antioxidants: potential implication in relation to the pathogenesis of Parkinson's disease. Journal of Neurochemistry. 74: 1605-12. PMID 10737618 DOI: 10.1046/j.1471-4159.2000.0741605.x |
0.316 |
|
| 1999 |
Liste I, Rodriguez-Pallares J, Caruncho HJ, Labandeira-Garcia JL. Locomotor-activity-induced changes in striatal levels of preprotachykinin and preproenkephalin mRNA. Regulation by the dopaminergic and glutamatergic systems. Brain Research. Molecular Brain Research. 70: 74-83. PMID 10381545 DOI: 10.1016/S0169-328X(99)00140-0 |
0.784 |
|
| 1997 |
Liste I, Caruncho HJ, Guerra MJ, Labandeira-Garcia JL. GABA(A) receptor subunit expression in intrastriatal striatal grafts comparison between normal developing striatum and developing striatal grafts. Brain Research. Developmental Brain Research. 103: 185-94. PMID 9427482 DOI: 10.1016/S0165-3806(97)81794-4 |
0.596 |
|
| 1997 |
Liste I, Guerra MJ, Caruncho HJ, Labandeira-Garcia JL. Treadmill running induces striatal Fos expression via NMDA glutamate and dopamine receptors. Experimental Brain Research. 115: 458-68. PMID 9262200 DOI: 10.1007/Pl00005715 |
0.633 |
|
| 1996 |
Caruncho HJ, Liste I, Pesold C, Impagnatiello F, Guidotti A, Labandeira-Garcia JL. Semiquantitative immunocytochemical analysis of GABAA receptor subunit expression in the rat neostriatum. Receptors & Channels. 4: 85-92. PMID 8865360 |
0.562 |
|
| 1996 |
Guerra MJ, Liste I, Rozas G, Tobio J, Labandeira-Garcia JL. Previous dopaminergic innervation is not necessary for the development of dopamine supersensitivity in rat striatal neurons. Neuroscience Letters. 206: 137-40. PMID 8710170 DOI: 10.1016/S0304-3940(96)12445-9 |
0.386 |
|
| 1995 |
Liste I, Rozas G, Guerra MJ, Labandeira-Garcia JL. Cortical stimulation induces Fos expression in striatal neurons via NMDA glutamate and dopamine receptors. Brain Research. 700: 1-12. PMID 8624698 DOI: 10.1016/0006-8993(95)00958-S |
0.328 |
|
| 1994 |
Labandeira-Garcia JL, Tobio JP, Guerra MJ. Comparison between normal developing striatum and developing striatal grafts using drug-induced Fos expression and neuron-specific enolase immunohistochemistry. Neuroscience. 60: 399-415. PMID 7915411 DOI: 10.1016/0306-4522(94)90253-4 |
0.404 |
|
| Show low-probability matches. |